Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Infectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
J Cosmet Dermatol. 2021 Nov;20(11):3364-3368. doi: 10.1111/jocd.14508. Epub 2021 Oct 7.
The various cutaneous manifestations have lately appeared in the setting of COVID-19. Psoriasis flare-ups have been reported during a COVID-19 infection.
We present a case of a 32-year-old woman with COVID-19 who presented with generalized pustular psoriasis. She received oral prednisolone, hydroxyzine, and topical clobetasol. The patient received follow-up two weeks later and found that her lesions were favorably desquamating.
The PubMed, SCOPUS, and ISI Web of Science databases were thoroughly searched for English studies reporting psoriasis flare-ups following SARS-CoV-2 infection. Ten case reports/series were included after screening.
Our case report brings awareness to clinicians for the possible cutaneous manifestation of COVID-19, which should be considered part of the differential diagnoses.
最近在 COVID-19 背景下出现了各种皮肤表现。有报道称在 COVID-19 感染期间出现了银屑病发作。
我们报告了一例 COVID-19 患者，她出现了全身性脓疱性银屑病。她接受了口服泼尼松龙、羟嗪和局部卤倍他索治疗。两周后对患者进行了随访，发现她的皮损正在顺利脱皮。
通过对 PubMed、SCOPUS 和 ISI Web of Science 数据库进行全面检索，查找了报告 SARS-CoV-2 感染后银屑病发作的英文研究。经过筛选，共纳入 10 例病例报告/系列。
我们的病例报告提醒临床医生注意 COVID-19 的可能皮肤表现，这应被视为鉴别诊断的一部分。
